Abstract
Purpose: This study aims to describe the cohort of Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) research program participants and evaluate whether the ATN's recently completed 5-year cycle recruited study participants who parallel the populations most impacted by HIV in the United States. Methods: Harmonized measures across ATN studies collected at baseline were aggregated for participants aged 13–24 years. Pooled means and proportions stratified by HIV status (at risk for or living with HIV) were calculated using unweighted averages of study-specific aggregate data. Medians were estimated using a weighted median of medians method. Public use 2019 Centers for Disease Control and Prevention surveillance data for state-level new HIV diagnoses and HIV prevalence among US youth aged 13–24 years were obtained for use as reference populations for ATN at-risk youth and youth living with HIV (YLWH), respectively. Results: Data from 3,185 youth at-risk for HIV and 542 YLWH were pooled from 21 ATN study phases conducted across the United States. Among ATN studies tailored to at-risk youth, a higher proportion of participants were White and a lower proportion were Black/African American and Hispanic/Latinx compared to youth newly diagnosed with HIV in the United States in 2019. Participants in ATN studies tailored to YLWH were demographically similar to YLWH in the United States. Discussion: The development of data harmonization guidelines for ATN research activities facilitated this cross-network pooled analysis. These findings suggest the ATN's YLWH are representative, but that future studies of at-risk youth should prioritize recruitment strategies to enroll more participants from African American and Hispanic/Latinx populations.
| Original language | English |
|---|---|
| Pages (from-to) | 712-721 |
| Number of pages | 10 |
| Journal | Journal of Adolescent Health |
| Volume | 72 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2023 |
Bibliographical note
Publisher Copyright:© 2023 Society for Adolescent Health and Medicine
Funding
The ATN is funded by the NIH through the Eunice Kennedy Shriver National Institute of Child Health and Human Development with supplemental funding from the National Institute of Mental Health, the National Institute on Drug Abuse, and the National Institute on Minority Health and Health Disparities. This research was supported by NIH grants U24HD089880, U19HD089875, U19HD089881, and 5U19HD089886. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Conflicts of interest: Dr. Arnold is a consultant on a project funded by Merck that is unrelated to the current project. All other authors have no potential conflicts of interest to declare. The ATN is funded by the NIH through the Eunice Kennedy Shriver National Institute of Child Health and Human Development with supplemental funding from the National Institute of Mental Health , the National Institute on Drug Abuse , and the National Institute on Minority Health and Health Disparities . This research was supported by NIH grants U24HD089880 , U19HD089875 , U19HD089881 , and 5U19HD089886 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | |
| National Institute of Mental Health | |
| National Institute on Drug Abuse | |
| Merck | |
| National Institute on Minority Health and Health Disparities (NIMHD) | U24HD089880, U19HD089875, U19HD089881, 5U19HD089886 |
| Eunice Kennedy Shriver National Institute of Child Health and Human Development |
Keywords
- Adolescent
- Adolescent medicine trials network for HIV/AIDS interventions
- Bisexual
- Data harmonization
- Gay
- HIV
- Transgender
- Youth
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Public Health, Environmental and Occupational Health
- Psychiatry and Mental health